New Role for FDA-Approved Drugs in Combating Antibiotic-Resistant Bacteria.

Andersson JA, Fitts EC, Kirtley ML, Ponnusamy D, Peniche AG, Dann SM, Motin VL, Chauhan S, Rosenzweig JA, Sha J, Chopra AK. New Role for FDA-Approved Drugs in Combating Antibiotic-Resistant Bacteria. Antimicrob Agents Chemother. 2016 06; 60(6):3717-29.

View in: PubMed

subject areas

Amoxapine
Animals
Anti-Inflammatory Agents, Non-Steroidal
Cell Survival
Disease Models, Animal
Doxapram
Drug Administration Schedule
Enterocolitis, Pseudomembranous
Female
High-Throughput Screening Assays
Macrophages
Mice
Plague
Prescription Drugs
Salmonella Infections
Salmonella typhimurium
Small Molecule Libraries
Survival Analysis
Trifluoperazine
Yersinia pestis

authors with profiles

Jason A. Rosenzweig

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support